Olympic Ophthalmics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $1M

  • Investors
  • 6

Olympic Ophthalmics General Information

Description

Manufacturer of treatment devices for ocular illnesses designed to treat dry eye disease. The company's device works by stimulating the trigeminal parasympathetic pathway to activate the glands responsible for tear film production, enabling healthcare workers to treat chronic dry eye in patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 160 North West Gilman Boulevard
  • Suite 412
  • Issaquah, WA 98027
  • United States
+1 (650)
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 160 North West Gilman Boulevard
  • Suite 412
  • Issaquah, WA 98027
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Olympic Ophthalmics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 14-Jul-2020 $1M Completed Generating Revenue
2. Early Stage VC (Series A1) 11-Dec-2019 Completed Generating Revenue
1. Early Stage VC (Series A) 08-Jan-2018 $2.4M $2.4M Completed Generating Revenue
To view Olympic Ophthalmics’s complete valuation and funding history, request access »

Olympic Ophthalmics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-1
Series A
To view Olympic Ophthalmics’s complete cap table history, request access »

Olympic Ophthalmics Patents

Olympic Ophthalmics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240374462-A1 Removable skin interface for functional enhancement of handheld vibrational device Pending 09-May-2023
US-11147737-B2 Handheld device with motorized member for treatment of disorders Active 26-Feb-2018
US-20190262173-A1 Handheld device with motorized member for treatment of disorders Active 26-Feb-2018
JP-7381088-B2 Handheld device with vibrating member for treatment of disorders Active 26-Feb-2018
JP-2021514810-A Handheld device with vibrating members for the treatment of disabilities Active 26-Feb-2018 A61H23/02
To view Olympic Ophthalmics’s complete patent history, request access »

Olympic Ophthalmics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Olympic Ophthalmics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Saints Capital Secondary Buyer Minority
Vertex Ventures HC Venture Capital Minority
Angel (individual) Minority
Angel (individual) Minority
Morgenthaler Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Olympic Ophthalmics FAQs

  • When was Olympic Ophthalmics founded?

    Olympic Ophthalmics was founded in 2017.

  • Where is Olympic Ophthalmics headquartered?

    Olympic Ophthalmics is headquartered in Issaquah, WA.

  • What is the size of Olympic Ophthalmics?

    Olympic Ophthalmics has 3 total employees.

  • What industry is Olympic Ophthalmics in?

    Olympic Ophthalmics’s primary industry is Therapeutic Devices.

  • Is Olympic Ophthalmics a private or public company?

    Olympic Ophthalmics is a Private company.

  • What is Olympic Ophthalmics’s current revenue?

    The current revenue for Olympic Ophthalmics is .

  • How much funding has Olympic Ophthalmics raised over time?

    Olympic Ophthalmics has raised $8.2M.

  • Who are Olympic Ophthalmics’s investors?

    Saints Capital, Vertex Ventures HC, , , and Morgenthaler are 5 of 6 investors who have invested in Olympic Ophthalmics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process